Yes, there is ongoing research aimed at understanding the molecular mechanisms underlying NF2 and developing new therapies. Advances in genomics and targeted therapies hold promise for improving outcomes for individuals with NF2. Clinical trials are also exploring the efficacy of new treatments and interventions.
